NCT00918281View on ClinicalTrials.gov

Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

September 30, 2011

Study Completion Date

October 31, 2011

Conditions
Solid TumorsHigh Grade GliomasLung CancerHead and Neck CancerSarcomaRenal Cell CarcinomaBreast Cancer
Interventions
DRUG

Fluciclatide Injection

Fluciclatide Injection (AH111585 (18F) Injection)

Trial Locations (1)

08540

101 Carnegie Center, Princeton

Sponsors

Lead Sponsor

GE Healthcare
All Listed Sponsors
collaborator

BIAFFIN GmbH & Co. KG (Biomolecular Interaction Analyses)

UNKNOWN

collaborator

Quintiles, Inc.

INDUSTRY

collaborator

i3 Statprobe

INDUSTRY

lead

GE Healthcare

INDUSTRY